A randomised controlled trial of outpatient compared with inpatient cervical ripening with prostaglandin <scp>E</scp><sub>2</sub> (<scp>OPRA</scp> study)

Chris Wilkinson, Robert L. Bryce, Pamela Adelson, Deborah Turnbull

BJOG An International Journal of Obstetrics & Gynaecology · 2014 · 56 citations · 18 references

Abstract

This study demonstrated no clinical advantage or disadvantage in prostaglandin E2 outpatient cervical ripening. Uterine stimulation following prostaglandins may preclude a woman from going home or remaining at home overnight and may not be the best agent for outpatient ripening.

References

18